跳至主要内容
临床试验/NCT06199141
NCT06199141已完成不适用

The Impact of Multi-drug Resistant Gram-negative Bacteria on Outcomes in Patients Requiring Veno-venous Extracorporeal Membrane Oxygenation (ECMO)

University of Padova1 个研究点 分布在 1 个国家目标入组 279 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
279
试验地点
1
主要终点
Incidence of MDR Gram negative bacteria acquired

研究概览

简要总结

Veno-venous extracorporeal membrane oxygenation (VV-ECMO) is a life-support technique used in patients with most severe acute respiratory distress syndrome (ARDS). ARDS is a life-threatening form of respiratory failure associated with a mortality rate of approximately 40-45%.Despite several studies confirming a real benefit of the use of ECMO in patients with ARDS who are unresponsive to conventional management, ECMO is still a complex and costly treatment that can be exposed to potential complications, such as nosocomial infections (NI).

详细描述

Noteworthy, the most frequent NIs occurring during VV-ECMO are pneumonia (>40%) and, secondly, blood-stream infections (3-18%). The situation is more challenging for Gram-negative bacilli: more than one-half of the Escherichia coli and more than one-third of the Klebsiella pneumoniae isolates were resistant to at least one antimicrobial group. Of note, an alarming increase in carbapenem resistance has been reported in several species, including K. pneumoniae (7.9% of isolates), P.aeruginosa (16.5% of isolates) and A. baumannii (>30% of isolates).

In fact, the isolation of MDROs has been shown to be an independent risk of death and of subsequent infections not only in critically ill patients but also in those patients requiring VV-ECMO (mortality rate between 56-68%). However, data are still conflicting about the exact incidence of multidrug resistant organisms (MDRO) during VV-ECMO and the impact on short- and mid-term outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • pregnancy
  • age < 18
  • uncompleted records
  • survival < 24h after ECMO connection

结局指标

主要结局

Incidence of MDR Gram negative bacteria acquired

时间窗: From ECMO connection up to 48 hours after ECMO de-connection

Incidence of MDR Gram negative bacteria acquired after ECMO connection (n° events/1.000 person-days of ECMO)

Overall incidence of MDR Gram negative bacteria isolations

时间窗: From ECMO connection up to 48 hours after ECMO de-connection

Overall incidence of MDR Gram negative bacteria isolations during ECMO (n° events/1.000 person-days of ECMO)

Incidence of MDR Gram negative bacteria isolated prior to ECMO connection

时间窗: At study enrollment

Incidence of patients requiring VV-ECMO with a previous MDR Gram negative bacteria

次要结局

  • Incidence of MDR-related colonizations (plus descriptive analysis)(From ECMO connection up to 48 hours after ECMO de-connection)
  • Incidence of MDR-related infections (plus descriptive analysis)(From ECMO connection up to 48 hours after ECMO de-connection)
  • Risk factors-mortality(At ECMO connection (baseline))

研究者

发起方
University of Padova
申办方类型
Other
责任方
Principal Investigator
主要研究者

Annalisa Boscolo

Co-investigator

University of Padova

研究点 (1)

Loading locations...

相似试验